跳至主要内容
临床试验/NCT03009188
NCT03009188已完成不适用

Genetic Findings in a Chinese Family With Axenfeld-Rieger Syndrom

Aier Eye Hospital, Changsha0 个研究点目标入组 9 人开始时间: 2016年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
9
主要终点
Novel genetic findings in a Chinese family with Axenfeld-Rieger syndrom

研究概览

简要总结

Axenfeld-Rieger syndrome (ARS) is a rare autosomal dominant disorder, characterized by anterior segment abnormalities and systemic abnormalities. To date,two major genes, forkhead box C1 (FOXC1) on chromosome 6p25 and pituitary homeobox 2 (PITX2) on chromosome 4q25, have been demonstrated to cause ARS. In this study, we performed complete ophthalmologic examinations and analysis of FOXC1 and PITX2 of a Chinese family with ARS.

详细描述

Two genetions of a Chinese family with ARS were recruited to Aier Eye Hospital of Changsha.

Clinical evaluations: We performed full ophthalmologic examinations of all subjects, including: visual acuity, intraocular pressure measurements (Goldman), slit lamp, anterior segment photography, visual field test (Humphrey 750, Carl Zeiss, Germany), Anterior segment OCT (Carl Zeiss, Germany). If the refractive medium is clear, we also performed funduscopy, gonioscopic and retinal nerve fiber layer (RNFL) thickness measurements (Carl Zeiss, Germany).

Mutation analysis: About 2 ml of venous blood sampled from each subject and collected in Vacutainer tubes (Sanjiu Medical Technology Co., Ltd., Liuyang, China) containing EDTA. Genomic DNA was extracted from each blood using a genomic DNA mini kit for blood (Life Technologies), All coding exons, with flanking intronic regions, of FOXC1 and PITX2 were amplified using PCR with primers. The amplifed DNA was purifed by agarose gel electrophoresis and sequenced on a 3730/3700xl automated DNA sequencer (Applied Biosystems).

研究设计

研究类型
Observational
观察模型
Family Based

入排标准

性别
All
接受健康志愿者

入选标准

  • a Chinese family with ARS

排除标准

  • 未提供

结局指标

主要结局

Novel genetic findings in a Chinese family with Axenfeld-Rieger syndrom

时间窗: Dec 1, 2016

次要结局

未报告次要终点

研究者

发起方
Aier Eye Hospital, Changsha
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kuanshu Li

MD-candidate

Aier Eye Hospital, Changsha

相似试验